Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer
The purpose of this study is to determine the feasibility and efficacy of preoperative nimotuzumab injection combined with concurrent chemoradiotherapy for initially inoperable, locally advanced cervical cancer.
Locally Advanced Cervical Cancer
OTHER: Nimotuzumab+chemoradiotherapy
Treatment related toxicities, Acute and chronic toxicities., at 1 year|Tumor response after preoperative treatment, assessed at 4-5 weeks after the completion of preoperative treatment
Progression-free survival, at 1 year|Overall survival, at 1 year
The purpose of this study is to determine the feasibility and efficacy of preoperative nimotuzumab injection combined with concurrent chemoradiotherapy for initially inoperable, locally advanced cervical cancer.